Deliverables

EXECUTIVE SUMMARY	TOPIC	DELIVERABLE	DATE
	Platform	D15.8 -  Final report on outreach activities	2018-06-30
	Platform	D15.7 -  Final Business Plan	2018-06-30
	Platform	D14.12 -  EMIF Platform	2018-06-30
	Platform	D14.11 -  System implementation feedback and evaluation report 4	2018-06-30
	Platform	D13.6 -  Final suite of modules and tools for data analysis	2018-06-30
	Platform	D12.7 -  Final report on data flows data integration processing and linkage	2018-06-30
	Platform	D12.6 -  Final version data extraction software	2018-06-30
	Platform	D11.6 -  Final Report on Harmonisation and Semantics	2018-06-30
	Platform	D10.5 -  Final version of the EMIF Code of Practice	2018-06-30
	Platform	D9.5 -  Final evaluation results and roadmap for future development	2018-06-30
	Metabolic	D8.5 -  Scientific publications describing the use of clinical trial and population-based studies to investigate the natural history of NAFLD	2018-06-30
	Metabolic	D8.4 -  Legal and Ethical Framework established	2018-06-30
	Metabolic	D8.3 -  Evaluation of liver function tests in placebo groups from existing clinical trials to try to determine factors that influence the nature	2018-06-30
	Metabolic	D8.2 -  Study report or manuscript on the calibration of the Framingham Risk score in European NAFLD patients	2018-06-30
	Metabolic	D8.1 -  Test efficiencies with respect to identification of clinical trial subjects and feasibility of recruitment	2018-06-30
	Metabolic	D7.4 -  Report describing tests of algorithms for clinical outcomes in diverse populations of obese adults and children	2018-06-30
	Metabolic	D7.3 -  Development of algorithms to predict clinical outcomes in obese adults and children	2018-06-30
	Metabolic	D7.2 -  Protocols for EMR data extraction and analysis to understand risk factors associated with metabolic diseases	2018-06-30
	Metabolic	D7.1 -  A report on the prevalence and overlap between obesity and the four endpoints of interest in a real world setting	2018-06-30
	Metabolic	D6.7 -  Report describing the association of potentially causal biomarkers with clinical outcomes in large-scale case-cohort studies	2018-06-30
	Metabolic	D6.6 -  Report describing causal significance of biomarkers associated with metabolic consequence of obesity	2018-06-30
	Metabolic	D6.5 -  Completion of a report describing the association of up to 6 novel biomarkers emerging from WP5 with the metabolic consequences of obesity	2018-06-30
	Metabolic	D5.4 -  Identify potential targets for drug development and diagnostic tests which meet standard clinical sensitivity and specificity criteria	2018-06-30
	Metabolic	D5.3 -  Functional assessment of novel biomarkers in cell models	2018-06-30
	Metabolic	D5.2 -  Identify novel biomarkers of risk in extreme phenotypes which exhibit adequate sensitivity and specificity	2018-06-30
	AD	D4.2 -  Screening algorithms tested and defined	2018-06-30
	AD	D4.1 -  Report on cross-validated plasma, genetic, CSF, MRI markers for diagnosis for predementia of AD	2018-06-30
	AD	D3.14 -  Report joint study AD-Metabolic	2018-06-30
	AD	D3.13 -  10 Assays of biomarkers for clinical use	2018-06-30
	AD	D3.12 -  Integrative model of biomarkers from different modalities	2018-06-30
	AD	D3.11 -  2 novel combinatorial MRI marker algorithms for prognosis	2018-06-30
	AD	D3.8 -  4 Epigenomic profiles associated with abnormal AD CSF biomarkers	2018-06-30
	AD	D3.6 -  4 GWAS-identified SNPs for abnormal CSF abeta and tau and hippocampal atrophy	2018-06-30
	AD	D3.4 -  2 Metabolomics based plasma markers for diagnosis	2018-06-30
	AD	D3.2 -  4 Proteomic based plasma markers for prognosis	2018-06-30
	AD	D3.1 -  4 Proteomic based plasma markers for diagnosis	2018-06-30
	AD	D2.6 -  Definition of extreme phenotypes based on resilience to dementia	2018-06-30
	AD	D2.2 -  Validated criteria for presymptomatic AD and prodromal AD	2018-06-30
	AD	D1.5 -  Cohort of cognitively normal subjects with 2-year follow-up data	2018-06-30
	AD	D1.4 -  Cohort of cognitively normal subjects with AD biomarkers baseline data	2018-06-30
	AD	D1.3 -  Dataset with EHR data linked to research cohort data	2018-06-30
	AD	D3.10 - Novel combinatorial MRI marker algorithms for diagnosis	2016-12-31
	Platform	D9.4 - Second framework evaluation results and requirements v3	2016-12-31
	Platform	D10.4 - First draft of the EMIF Ethical Code of Practice	2016-12-31
	Platform	D11.5 - Second version of the harmonised information model and associated terminology mapping	2016-12-31
	Platform	D14.9 - System implementation feedback and evaluation report, iteration 3	2016-12-31
	Platform	D14.10 - EMIF Platform, version 4	2016-12-31
	Platform	D15.6 - Update to Business Plan - February 2017	2016-12-31
	PMO	D16.16 - Technical and Financial Annual Reports #4	2016-12-31
	AD	D3.3 - 2 Proteomic based CSF markers for prognosis	2016-12-31
	AD	D1.2 - Private Remote Research database environment with pooled data from research cohorts	2015-06-30
	AD	D2.1 - Summary statistics of cohorts included	2015-12-31
	AD	D2.2 - Validated criteria for presymptomatic AD and prodromal AD	2015-12-31
	AD	D2.3 - Definition of extreme phenotypes based on cognitive decline	2015-12-31
	AD	D2.4 - Prediction model for cognitive decline	2015-12-31
	AD	D2.5 - Definition of extreme phenotypes based on AD biomarkers	2015-12-31
	AD	D1.1 - Report on the overview of available data sources	2013-12-31
	Metabolic	D5.1 - Establishing functional datawarehousing and management	2013-12-31
	Metabolic	D6.1 - Analytical framework to investigate metabolic predictors of the complications of obesity	2013-12-31
	Metabolic	D6.2 - A report describing the systematic review of candidate biomarkers for the prediction of the metabolic consequences of obesity	2014-06-30
	Metabolic	D6.8 - Investigation of the causal nature of associations between obesity and selected obesity-related complications	2014-12-31
	Metabolic	D6.3 - A report describing the association of up to 6 candidate biomarkers with metabolic traits in up to 20 000 participants in well-phenotyped metabolically phenotyped studies	2015-12-31
	Metabolic	D6.4 - A report describing the association of a metabolomic profile with the metabolic complications of obesity in up to 20 000 participants in well-phenotyped metabolically phenotyped studies	2015-12-31
	Platform	D9.2 - Platform requirements v1 and evaluation plan	2013-12-31
	Platform	D10.3 - Full database fingerprinting	2013-12-31
	Platform	D11.2 - First version of common data model and associated terminology mapping	2013-12-31
	Platform	D12.1 - Data extraction software v1	2013-12-31
	Platform	D14.2 - A data management solution for vertical projects, version 1	2013-12-31
	Platform	D14.3 - EMIF-Platform, version 1	2013-12-31
	Platform	D15.1 - Report on business models for data exploitation in biosciences	2013-12-31
	Platform	D14.4 - System implementation feedback and evaluation report, iteration 1	2014-04-30
	Platform	D11.3 - Extended specification of the semantic framework of reference	2014-06-30
	Platform	D13.1 - Evaluation of technologies and tools available for data analysis and visualization	2014-06-30
	Platform	D9.1 - Initial requirements set	2013-02-28
	Platform	D15.2 - Market analysis: usage models and data sources characterization	2014-08-31
	Platform	D9.3 - Interim framework evaluation results and requirements v2	2014-12-31
	Platform	D12.2 - Data extraction software v2	2014-12-31
	Platform	D12.3 - Interim report on primary data flows, benchmarking and quality analyses	2014-12-31
	Platform	D13.2 - Data analysis tools for vertical projects v1	2014-12-31
	Platform	D14.5 - A data management solution for vertical projects, v2	2014-12-31
	Platform	D14.6 - EMIF-Platform, version 2	2014-12-31
	Platform	D15.3 - Initial business model description	2014-12-31
	Platform	D11.4 - Second version of common data model and associated terminology mapping	2014-12-31
	Platform	D15.4 - First report on outreach activities: leveraging with related initiatives, contacts with external data sources and with key stakeholders	2015-04-30
	Platform	D10.1 - Initial database fingerprinting	2013-03-31
	Platform	D13.3 - Data analysis and visualization tools, including workflows for linkage with omics data v1	2015-06-30
	Platform	D14.7 - First EMIF-Platform architecture stack	2015-08-31
	Platform	D11.4 - First complete version of the harmonised information model and associated terminology mapping	2015-12-31
	Platform	D12.4 - Interim report on data linkage	2015-12-31
	Platform	D12.5 - Interim report on specialised data extraction, benchmarking, aggregation and processing	2015-12-31
	Platform	D13.4 - Data analysis tools for vertical projects v2	2015-12-31
	Platform	D14.8 - EMIF-Platform, version 3	2015-12-31
	Platform	D15.5 - First draft of business plan	2015-12-31
	Platform	D10.2 - First report on federation procedures, ethical and legal issues	2013-06-30
	Platform	D11.1 - Initial specification of the semantic framework of reference	2013-06-30
	Platform	D14.1 - First report on EMIF-Platform desing and architecture including specifications for privacy protection tools and services	2013-06-30
	Platform	D13.5 - Data analysis and visualisation tools, including workflows for linkage with omics data v2	2016-10-31
	PMO	D16.1 - Operational portal to allow internal team information dissemination, team collaboration, and team document storage	2013-01-31
	PMO	D16.12 - Technical and financial annual report #1	2013-12-31
	PMO	D16.11 - Updated project and risk plans for WP1-15	2014-12-31
	PMO	D16.13 - Technical and financial annual report #2	2014-12-31
	PMO	D16.2 - Templates for dissemination materials: logo design, ppt and poster templates, newsletter formats	2013-03-31
	PMO	D16.14 - Interim assessment of the project	2015-08-31
	PMO	D16.15 - Technical and financial annual report #3	2015-12-31
	PMO	D16.4 - Communication plan	2013-06-30
	PMO	D16.5 - Project handbook	2013-06-30
	PMO	D16.6 - Guidance document for EMIF scientific publications	2013-06-30
	PMO	D16.9 - Operational website for both internal use and external dissemination	2013-06-30
	PMO	D16.10 - Detailed project and risk plans for WP1-15	2013-06-30